Clinical utility of neuronal cells directly converted from fibroblasts of patients for neuropsychiatric disorders: studies of lysosomal storage diseases and channelopathy.
Clinical utility of neuronal cells directly converted from fibroblasts of patients for neuropsychiatric disorders: studies of lysosomal storage diseases and channelopathy.
复制标题
神经元细胞的临床实用性直接从患者的成纤维细胞转化为神经精神疾病:溶酶体储存疾病和通道疗法的研究。
DOI:
10.2174/1566524015666150303110300
复制
发表时间:
2015
影响因子:
2.5
通讯作者:
Kai M
中科院分区:
文献类型:
--
作者:
Kano S;Yuan M;Cardarelli RA;Maegawa G;Higurashi N;Gaval-Cruz M;Wilson AM;Tristan C;Kondo MA;Chen Y;Koga M;Obie C;Ishizuka K;Seshadri S;Srivastava R;Kato TA;Horiuchi Y;Sedlak TW;Lee Y;Rapoport JL;Hirose S;Okano H;Valle D;O'Donnell P;Sawa A;Kai M
Methodologies for generating functional neuronal cells directly from human fibroblasts [induced neuronal (iN) cells] have been recently developed, but the research so far has only focused on technical refinements or recapitulation of known pathological phenotypes. A critical question is whether this novel technology will contribute to elucidation of novel disease mechanisms or evaluation of therapeutic strategies. Here we have addressed this question by studying Tay-Sachs disease, a representative lysosomal storage disease, and Dravet syndrome, a form of severe myoclonic epilepsy in infancy, using human iN cells with feature of immature postmitotic glutamatergic neuronal cells. In Tay-Sachs disease, we have successfully characterized canonical neuronal pathology, massive accumulation of GM2 ganglioside, and demonstrated the suitability of this novel cell culture for future drug screening. In Dravet syndrome, we have identified a novel functional phenotype that was not suggested by studies of classical mouse models and human autopsied brains. Taken together, the present study demonstrates that human iN cells are useful for translational neuroscience research to explore novel disease mechanisms and evaluate therapeutic compounds. In the future, research using human iN cells with well-characterized genomic landscape can be integrated into multidisciplinary patient-oriented research on neuropsychiatric disorders to address novel disease mechanisms and evaluate therapeutic strategies.
登录
查看更多内容
影响因子:
3.6
作者:
Higurashi N;Uchida T;Lossin C;Misumi Y;Okada Y;Akamatsu W;Imaizumi Y;Zhang B;Nabeshima K;Mori MX;Katsurabayashi S;Shirasaka Y;Okano H;Hirose S
通讯作者:
Hirose S
影响因子:
64.8
作者:
Israel, Mason A.;Yuan, Shauna H.;Bardy, Cedric;Reyna, Sol M.;Mu, Yangling;Herrera, Cheryl;Hefferan, Michael P.;Van Gorp, Sebastiaan;Nazor, Kristopher L.;Boscolo, Francesca S.;Carson, Christian T.;Laurent, Louise C.;Marsala, Martin;Gage, Fred H.;Remes, Anne M.;Koo, Edward H.;Goldstein, Lawrence S. B.
通讯作者:
Goldstein, Lawrence S. B.
影响因子:
64.8
作者:
Vierbuchen, Thomas;Ostermeier, Austin;Pang, Zhiping P.;Kokubu, Yuko;Suedhof, Thomas C.;Wernig, Marius
通讯作者:
Wernig, Marius
影响因子:
64.5
作者:
Dolmetsch R;Geschwind DH
通讯作者:
Geschwind DH
影响因子:
120.7
作者:
Meikle, PJ;Hopwood, JJ;Carey, WF
通讯作者:
Carey, WF